China Resources Medical Holdings Company Limited (FRA:1PH)
Germany · Delayed Price · Currency is EUR 0.3400
-0.0040 (-1.16%)
At close: Jan 30, 2026
FRA:1PH Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 471.45 | 565.88 | 257.68 | 265.86 | 417.92 | 310.13 |
Depreciation & Amortization | 604.98 | 618.9 | 610.86 | 486.41 | 182.88 | 113.38 |
Loss (Gain) From Sale of Assets | 11.19 | 11.19 | 2.39 | -5.41 | - | - |
Asset Writedown & Restructuring Costs | 32.15 | 32.15 | 351.81 | 108.83 | 11.15 | 3.59 |
Loss (Gain) From Sale of Investments | 22.15 | 22.15 | 145.87 | 22.18 | 371.56 | 45.08 |
Loss (Gain) on Equity Investments | -98.6 | -98.6 | -90.78 | -88.07 | -83.55 | -34.97 |
Stock-Based Compensation | - | - | - | 2.16 | 10.11 | 8.72 |
Other Operating Activities | 291.5 | 96.98 | 230.61 | 159.42 | -348.79 | -101.65 |
Change in Accounts Receivable | 118.03 | 118.03 | -111.25 | 109.17 | 131.47 | 81.1 |
Change in Inventory | -0.07 | -0.07 | 65.18 | -17.34 | 0.21 | -23.29 |
Change in Accounts Payable | -35.24 | -35.24 | 9.71 | -152.76 | -31.99 | 82.01 |
Change in Unearned Revenue | 2.23 | 2.23 | 17.21 | 8.54 | -0.09 | - |
Change in Other Net Operating Assets | -63.34 | -63.34 | -294.17 | -35.4 | 49.56 | 159.59 |
Operating Cash Flow | 1,356 | 1,270 | 1,195 | 863.59 | 710.43 | 643.69 |
Operating Cash Flow Growth | 16.69% | 6.29% | 38.39% | 21.56% | 10.37% | 75.85% |
Capital Expenditures | -532.37 | -563.69 | -486.68 | -466.28 | -198.43 | -209.55 |
Sale of Property, Plant & Equipment | -2.51 | 0.09 | 54.98 | 6.13 | 2.1 | 7.4 |
Cash Acquisitions | - | - | -3,768 | 173.92 | -669.61 | 49.52 |
Divestitures | - | - | - | 0.01 | - | - |
Sale (Purchase) of Intangibles | - | - | - | - | - | -8 |
Investment in Securities | -50 | - | 872.18 | 381.34 | -1,096 | 160.8 |
Other Investing Activities | 45.43 | 18.88 | 705.46 | -589.13 | 26.26 | 60.19 |
Investing Cash Flow | -539.45 | -544.73 | -2,622 | -494.02 | -1,936 | 60.37 |
Short-Term Debt Issued | - | - | - | - | - | 455.24 |
Long-Term Debt Issued | - | 1,724 | 5,554 | 8,614 | 6,073 | - |
Total Debt Issued | 2,364 | 1,724 | 5,554 | 8,614 | 6,073 | 455.24 |
Short-Term Debt Repaid | - | - | - | -0.26 | -1.56 | -315.44 |
Long-Term Debt Repaid | - | -2,489 | -5,819 | -8,650 | -5,106 | -8.68 |
Total Debt Repaid | -3,068 | -2,489 | -5,819 | -8,651 | -5,107 | -324.12 |
Net Debt Issued (Repaid) | -703.51 | -764.34 | -265.28 | -36.68 | 965.15 | 131.12 |
Issuance of Common Stock | - | - | - | - | 0.54 | 0.98 |
Common Dividends Paid | -139.13 | -139.13 | -42.35 | -129.6 | -91.08 | -115.09 |
Other Financing Activities | -70.15 | -81.32 | -129.45 | -57.41 | -28.66 | -24.38 |
Financing Cash Flow | -912.79 | -984.8 | -437.08 | -223.69 | 845.96 | -7.38 |
Foreign Exchange Rate Adjustments | -0.03 | 0.5 | 0.14 | 2.73 | 2.34 | -1.52 |
Net Cash Flow | -95.85 | -258.76 | -1,864 | 148.61 | -377.32 | 695.15 |
Free Cash Flow | 824.06 | 706.57 | 708.44 | 397.31 | 512 | 434.14 |
Free Cash Flow Growth | 32.68% | -0.26% | 78.31% | -22.40% | 17.93% | 31.68% |
Free Cash Flow Margin | 8.76% | 7.17% | 7.01% | 5.03% | 11.51% | 15.78% |
Free Cash Flow Per Share | 0.65 | 0.56 | 0.56 | 0.32 | 0.41 | 0.34 |
Cash Interest Paid | 52.53 | 63.7 | 116.27 | 56.4 | 19.77 | 14.22 |
Cash Income Tax Paid | 235.69 | 235.69 | 163.4 | 143.84 | 135.99 | 98.27 |
Levered Free Cash Flow | 409.24 | 280.26 | 1,843 | 235.59 | 569.68 | 555.25 |
Unlevered Free Cash Flow | 439.55 | 318.39 | 1,915 | 270.53 | 579.83 | 565.89 |
Change in Working Capital | 21.62 | 21.62 | -313.31 | -87.79 | 149.17 | 299.41 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.